Breast implants showed possible increased risk of rare cancer says FDA
(Best Syndication News) - The US Food and Drug Administration (FDA) announced a potential associated increased risk of saline and silicone gel-filled breast implants and a rare anaplastic large cell lymphoma cancer. The increased risk is small said the FDA, but at the same time is significant.
The FDA is asking health care professionals to report any women that have been diagnosed with anaplastic large cell lymphoma cancer so they can further evaluate this potential risk for ALCL cancer and breast implants. Because of the potential cancer risk, the FDA will be working with breast implant manufacturing companies to include notices of the cancer risk.
The National Cancer Institute said that ALCL is diagnosed in 1 out of 500,000 women each year. ALCL found in breast tissue is diagnosed 3 out of every 100 million in women without breast implants every year.
The FDA is aware of 60 ALCL cases in women with breast implants around the world but the actual numbers are not known. The FDA have used scientific literature and medical reports that was published between 1997 and May 2010 and found 34 unique cases of ALCL in women who also had both saline and silicone breast implants.
Diagnosis of these ALCL cases occurred usually because the patients had breast implant related symptoms. These symptoms included pain, lumps, swelling, and asymmetry after the surgery healed completely.
The ALCL cancer is rare. There are currently between 5 and 10 million women worldwide that have breast implants. The FDA said that women with breast implants should continue with their regular routine medical care and follow up and don't need to change this. However if women notice changes in their breast implants they should seek their doctor's consultation.
BY: N Wilson